The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Mefatinib as first-line treatment of EGFR sensitizing mutation-positive non-small-cell lung cancer: A phase III efficacy and biomarker study.
 
Jia Yu
No Relationships to Disclose
 
Caicun Zhou
No Relationships to Disclose
 
Wang Kai
No Relationships to Disclose
 
Qiming Wang
No Relationships to Disclose
 
Hongrui Niu
No Relationships to Disclose
 
Cheng-Zhi Zhou
No Relationships to Disclose
 
Panwen Tian
No Relationships to Disclose
 
Wu Zhuang
No Relationships to Disclose
 
Jie Li
No Relationships to Disclose
 
Jing Wang
No Relationships to Disclose
 
Xu Sun
Employment - Huadong Medicine
Stock and Other Ownership Interests - Huadong Medicine
 
Bing Yu
Employment - Huadong Medicine
 
Chaonan Zhu
Employment - Huadong Medicine
 
Jianghua Chen
Employment - Huadong Medicine
 
June Xu
Employment - Huadong Medicine
Leadership - Huadong Medicine
Stock and Other Ownership Interests - Huadong Medicine
Honoraria - Huadong Medicine